Stem Cell Therapy for Parkinson’s Disease in Japan: What Are the Options?
Japan has conditionally approved AMCHEPRY, an iPS cell-derived treatment for Parkinson’s movement symptoms that are not adequately controlled by medication. […]
Japan has conditionally approved AMCHEPRY, an iPS cell-derived treatment for Parkinson’s movement symptoms that are not adequately controlled by medication. […]
Yes, some clinics can review your MRI before you travel. The important part is making sure the review is actually
Not necessarily. Japan does not have one referral rule for every hospital or regenerative medicine program. The requirement depends on
Yes. In many cases, you can speak with a medical provider in Japan before sending your full medical file. You
In many cases, yes. A remote consultation can help you find out whether a trip to Japan is worth considering
For a first consultation, you usually need a short medical summary, a few key specialist reports, recent relevant imaging, useful
PRP and cell injections differ in evidence, preparation and cost. Compare the knee osteoarthritis research and plan treatment in Japan with those differences in mind.
For an initial stem cell consultation in Japan, records that describe your current health are most useful when they cover
No. Most patients should not stop all of their medicines before stem cell therapy in Japan. Some drugs may need
Most patients do not need one fixed “Japan stem cell blood panel.” The test list changes with the cell source,